Literature DB >> 28549747

Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress.

Yanna Lei1, Guang Yang2, Lina Hu3, Limei Piao2, Aiko Inoue1, Haiying Jiang4, Takeshi Sasaki5, Guangxian Zhao1, Maimaiti Yisireyili6, Chenglin Yu1, Wenhu Xu1, Kyosuke Takeshita6, Kenji Okumura6, Masafumi Kuzuya7, Xian Wu Cheng8.   

Abstract

OBJECTIVES: Exposure to psychosocial stress is a risk factor for cardiovascular disease. Given that dipeptidyl peptidase-4 (DPP4) regulates several intracellular signaling pathways associated with glucagon-like peptide-1 (GLP-1) metabolism, we investigated the role of DPP4 in stress-related vascular senescence and atherosclerosis in apolipoprotein E-deficient (ApoE-/-) mice. METHODS AND
RESULTS: ApoE-/- mice fed a high-fat (HF) diet were randomly assigned to one of non-stress and immobilized stress groups for 12weeks. Chronic stress accelerated vascular senescence and atherosclerotic plaque growth at the aortic roots. Stressed mice had increased levels of plasma DPP4 and decreased levels of plasma GLP-1 and adiponectin (APN) and adipose APN expression. Stress increased plaque macrophage infiltration, neovessel density, and elastin fragmentation, lessened the plaque collagen content, and increased the levels of toll-like receptor-2 (TLR2), TLR4, C-X-C chemokine receptor-4, cathepsins S and K, osteopontin, peroxisome proliferator-activated receptor-α, p16INK4A, p21, and gp91phox mRNAs and/or proteins. Stressed aortas had also increased matrix metalloproteinase-2 (MMP-2) and MMP-9 activities. DPP4 inhibition with anagliptin reversed stress-related atherosclerotic lesion formation, and this benefit was abrogated by APN blocking. In vitro, the GLP-1 receptor agonist exenatide stimulated APN expression in 3T3-L1 cells.
CONCLUSIONS: These results indicate that the DPP4 inhibition-mediated benefits are likely attributable, at least in part, to attenuation of plaque inflammation, oxidative stress and proteolysis associated with GLP-1-mediated APN production in ApoE-/- mice under stress. Thus, DPP4 will be a novel therapeutic target for the treatment of stress-related cardiovascular disease.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Chronic stress; Dipeptidyl peptidase-4; Inflammation; Vascular senescence

Mesh:

Substances:

Year:  2017        PMID: 28549747     DOI: 10.1016/j.ijcard.2017.05.062

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  20 in total

1.  Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress.

Authors:  Xueling Yue; Limei Piao; Hailong Wang; Zhe Huang; Xiangkun Meng; Takeshi Sasaki; Aiko Inoue; Kae Nakamura; Ying Wan; Shengnan Xu; Guo-Ping Shi; Weon Kim; Toyoaki Murohara; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Hypertension       Date:  2022-06-21       Impact factor: 9.897

2.  Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.

Authors:  Enbo Zhu; Lina Hu; Hongxian Wu; Limei Piao; Guangxian Zhao; Aiko Inoue; Weon Kim; Chenglin Yu; Wenhu Xu; Yasuko K Bando; Xiang Li; Yanna Lei; Chang-Ning Hao; Kyosuke Takeshita; Woo-Shik Kim; Kenji Okumura; Toyoaki Murohara; Masafumi Kuzuya; Xian Wu Cheng
Journal:  J Am Heart Assoc       Date:  2017-07-14       Impact factor: 5.501

3.  RP105 plays a cardioprotective role in myocardial ischemia reperfusion injury by regulating the Toll‑like receptor 2/4 signaling pathways.

Authors:  Weiling Huang; Jian Yang; Chao He; Jun Yang
Journal:  Mol Med Rep       Date:  2020-06-16       Impact factor: 2.952

4.  111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis.

Authors:  Roberto Mota; Matthew J Campen; Matthew E Cuellar; William S Garver; Jacob Hesterman; Mohammed Qutaish; Tamara Daniels; Monique Nysus; Carston R Wagner; Jeffrey P Norenberg
Journal:  Contrast Media Mol Imaging       Date:  2018-11-13       Impact factor: 3.161

5.  Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease.

Authors:  Takanobu Takata; Akiko Sakasai-Sakai; Tadashi Ueda; Masayoshi Takeuchi
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

6.  Cathepsin S Deficiency Mitigated Chronic Stress-Related Neointimal Hyperplasia in Mice.

Authors:  Hailong Wang; Xiangkun Meng; Limei Piao; Aiko Inoue; Wenhu Xu; Chenglin Yu; Kae Nakamura; Lina Hu; Takeshi Sasaki; Hongxian Wu; Kazumasa Unno; Hiroyuki Umegaki; Toyoaki Murohara; Guo-Ping Shi; Masafumi Kuzuya; Xian Wu Cheng
Journal:  J Am Heart Assoc       Date:  2019-07-12       Impact factor: 5.501

7.  Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis.

Authors:  Yi Li; Rong Li; Ziqian Feng; Qin Wan; Jianbo Wu
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

8.  Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.

Authors:  Limei Piao; Guangxian Zhao; Enbo Zhu; Aiko Inoue; Rei Shibata; Yanna Lei; Lina Hu; Chenglin Yu; Guang Yang; Hongxian Wu; Wenhu Xu; Kenji Okumura; Noriyuki Ouchi; Toyoaki Murohara; Masafumi Kuzuya; Xian Wu Cheng
Journal:  J Am Heart Assoc       Date:  2017-09-28       Impact factor: 5.501

9.  Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice.

Authors:  Tae H Ban; Eun N Kim; Min Y Kim; Ji H Lim; Jong H Lee; Hyung D Kim; Hye E Yoon; Cheol W Park; Bum S Choi
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

10.  Statins Mitigate Stress-Related Vascular Aging and Atherosclerosis in apoE-Deficient Mice Fed High Fat-Diet: The Role of Glucagon-Like Peptide-1/Adiponectin Axis.

Authors:  Yanna Lei; Qingsong Cui; Guang Yang; Limei Piao; Aiko Inoue; Hongxian Wu; Xiang Li; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Front Cell Dev Biol       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.